Back |
home / stock / ntla / ntla message board
Subject | By | Source | When |
---|---|---|---|
Currently, the company is using CRISPR/Cas9 screening to | jondoeuk | investorshub | 11/25/2020 7:58:37 PM |
Preclinical data (at ASH) https://ashpublications.org/blood/article/136/Suppleme | jondoeuk | investorshub | 11/04/2020 11:06:01 PM |
Bought more at $18.30 before selling all @ | chmcnfunds | investorshub | 01/08/2018 6:50:15 PM |
CRISPR hits a snag: Our immune systems may | chmcnfunds | investorshub | 01/08/2018 3:57:51 PM |
In at $18.90. Got to believe the drop | chmcnfunds | investorshub | 01/08/2018 3:56:50 PM |
I don't have enough understanding on how the | rule_rationale | investorshub | 10/09/2017 5:19:13 PM |
Am I the only one that thinks this | jimski55 | investorshub | 10/06/2017 7:38:42 PM |
Which of the big three is closest to | redspinelpinktopaz | investorshub | 03/07/2017 7:18:43 PM |
Took a starter here, CRISPR could do amazing things! | rule_rationale | investorshub | 05/10/2016 3:00:34 PM |
News, Short Squeeze, Breakout and More Instantly...
Intellia Therapeutics Inc. Company Name:
NTLA Stock Symbol:
NASDAQ Market:
Intellia Therapeutics Inc. Website:
2024-07-03 11:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-02 08:30:00 ET It was a rough first half of the year for Cathie Wood. The co-founder, CEO, and investor at Ark Invest saw her family of aggressive growth exchange-traded funds lose badly to the market. But she's not throwing in the towel. Wood publishes Ark's daily transactions,...